top of page

KIDNEY TRANSPLANTATION STUDIES

MERCURY

STUDY HOME

OPEN ENROLLMENT

Novel desensitization protocol for highly sensitized patients to allow for successful kidney transplantation.
A pilot study. (IRB21-0323-CR001)

COMPLETED

A Phase 2a, Randomized, Open-Label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis (FSGS) in de novo Kidney Transplant Recipients.

Funded by Astellas Pharma Global Development, Inc.

COMPLETED

Read more

Mercury- Living Donor Kidney Tx (with Bone Marrow)

A Phase 3 Prospective, Randomized, Multi-center, Open-label, Controlled Trial to Assess the Efficacy and Safety of Cellular Immunotherapy with MDR-101 for Induction of Immune Tolerance in Recipients of HLA-matched, Living Donor Kidney Transplants

Funded by Medeor Therapeutics, Inc

COMPLETED

A randomized double-blind placebo-controlled study to evaluate the efficacy and safety of CINRYZE® (C1 esterase inhibitor [human]) for the treatment of acute antibody-mediated rejection in kidney transplant patients.

Funded by Shire ViroPharma, Inc..

COMPLETED

A Phase 2a, Randomized, Open-Label, Active Control, Multi- Center Study to Assess the Efficacy and Safety of ASKP1240 in de novo Kidney Transplant Recipients

Funded by Astellas Pharma Global Development, Inc.

COMPLETED

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ from a CMV-Seropositive Donor.

Funded by Astellas Pharma Global Development, Inc.

bottom of page